Contrast Enhanced Ultrasound for the characterization of focal liver lesions

Medical Ultrasonography

Volumn 13, Issue 1, 2011, Pages 38-44

  Sporea, Ioan ^a   Badea, Radu ^b   Martie, Alina ^a   Şirli, Roxana ^a   Socaciu, Mihai ^b   Popescu, Alina ^a   Dǎnilǎ, Mirela ^a  

^a VICTOR BABES UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Contrast Enhanced Ultrasound (CEUS); Focal Liver Lesions (FLL); Ultrasound Contrast Agent (SonoVue)

Indexed keywords

SONOVUE;

ARTICLE; BILE DUCT TUMOR; CHRONIC LIVER DISEASE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FOCAL LIVER INJURY; HEMANGIOMA; HEPATOBLASTOMA; HUMAN; HUMAN TISSUE; LIVER ABSCESS; LIVER ADENOMA; LIVER BIOPSY; LIVER CANCER; LIVER HEMATOMA; LIVER INJURY; LIVER METASTASIS; LIVER TUMOR; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRACTICE GUIDELINE; SINGLE DRUG DOSE;

ADULT; AGED; AGED, 80 AND OVER; CONTRAST MEDIA; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PHOSPHOLIPIDS; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; ROMANIA; SULFUR HEXAFLUORIDE; ULTRASONOGRAPHY;

EID: 79952473039     PISSN: 18444172     EISSN: 20668643     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Albrecht T, Blomley M, Bolondi L, et al. EFSUMB Study Group. Guidelines for the use of contrast agents in ultrasound. January 2004. Ultraschall Med 2004; 25: 249-256.
2. Claudon M, Cosgrove D, Albrecht T, et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) - Update 2008. Ultraschall Med 2008; 29: 28-44.
3. Strobel D, Seitz K, Blank W, et al. Contrast-enhanced ultrasound for the characterization of focal liver lesions-diagnostic accuracy in clinical practice (DEGUM multicenter trial). Ultraschall Med 2008; 29: 499-505.
4. Tranquart F, Le Gouge A, Correas JM, et al. Role of contrast-enhanced ultrasound in the blinded assessment of focal lesions in comparison with MDCT and CEMRI: Results from a multicentre clinical trial. EJC 2008; Suppl.6: 9-15.
5. Seitz K, Strobel D, Bernatik T, et al. Contrast-Enhanced Ultrasound (CEUS) for the characterization of focal liver lesions - prospective comparison in clinical practice: CEUS vs. CT (DEGUM multicenter trial). Ultraschall Med 2009; 30: 383-389.
6. Braun B. Focal liver processes: "better is the enemy of good" : CEUS in the fast lane. Ultraschall Med 2009; 30: 329-332.
7. Wilson SR, Greenbaum LD, Goldberg BB. Contrast-enhanced ultrasound: what is the evidence and what are the obstacles. AJR Am J Roentgenol 2009; 193: 55-60.
8. Wang WP, Wu Y, Luo Y, et al: Clinical value of contrastenhanced ultrasonography in the characterization of focal liver lesions: a prospective multicenter trial. Hepatobiliary Pancreat Dis Int 2009; 4: 370-376.
9. Trillaud H, Bruel JM, Valette PJ, et al. Characterization of focal liver lesions with SonoVue- enhanced sonography: international multicenter-study in comparison to CT and MRI. World J Gastroenterol 2009; 15: 3748-3756.
10. Quaia E, Calliada F, Bertolotto, et al. Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence. Radiology 2004; 232: 420-430.
11. von Herbay A, Vogt C, Willers R, Häussinger D. Real-time imaging with the sonographic contrast agent SonoVue: differentiation between benign and malignant hepatic lesions. J Ultrasound Med 2004; 23: 1557-1568.
12. Strobel D, Seitz K, Blank W, et al. Tumor-specific vascularization pattern of liver metastasis, hepatocellular carcinoma, hemangioma and focal nodular hyperplasia in the differential diagnosis of 1,349 liver lesions in contrastenhanced ultrasound (CEUS). Ultraschall Med 2009; 30: 376-382.
13. Piscaglia F, Bolondi L; Italian Society for Ultrasound in Medicine and Biology (SIUMB) Study Group on Ultrasound Contrast Agents. The safety of SonoVue in abdominal applications: retrospective analysis of 23188 investigations. Ultrasound Med Biol 2006; 32: 1369-1375.
14. Seitz K, Bernatik T, Strobel D, et al. Contrast-Enhanced Ultrasound (CEUS) for the characterization of focal liver lesions in clinical practice (DEGUM Multicenter Trial): CEUS vs. MRI - a prospective comparison in 269 patients. Ultraschall Me. 2010; 31: 492-499.
15. Sporea I, Sirli R, Martie A, Popescu A, Danila M. How useful is contrast enhanced ultrasound for the characterization of focal liver lesions? J Gastrointestin Liver Dis 2010; 19: 393-398.
16. Tranquart F, Correas JM, Ladam Marcus V, et al. Echographie de contraste temps reel dans la prise en charge diagnostique des lesions nodulaires hepatiques: evaluation des performances diagnostiques et de l'impact economique sur une etude multicentrique francaise. J Radiol 2009; 90: 109-122.
17. Romanini L, Passamonti M, Aiani L, et al. Economic assessment of contrast-enhanced ultrasonography for evaluation of focal liver lesions: a multicentre Italian experience. Eur Radiol 2007;17 Suppl 6: F99-106.
18. Giesel FL, Delorme S, Sibbel R, Kauczor HU, Krix M. Contrast-enhanced ultrasound for the characterization of incidental liver lesions - an economical evaluation in comparison with multi-phase computed tomography. Ultraschall Med 2009; 30: 259-268.